Kineret® improves clinical outcomes in hospitalised patients with COVID-19 pneumonia
Treating moderate to severe COVID-19 pneumonia patients with poor prognosis…
Treating moderate to severe COVID-19 pneumonia patients with poor prognosis with Kineret® (anakinra) prevented death and progression to severe respiratory failure.